Skip to content

Expiring federal contract

HT942523C0095 — Versiti Blood Health, INC.

Department of Defense · Defense Health Agency

Contract / PIID
HT942523C0095
Incumbent
Versiti Blood Health, INC.
Incumbent UEI
JZDRNT166LE4
Current end date
December 24, 2026
Potential total value
$6,485,297
Obligated
$6,485,297
NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Set-aside
Full & Open
Start date
September 25, 2023
Place of performance
WI
Award type
DEFINITIVE CONTRACT

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

RESEARCH AND DEVELOPMENT CONTRACT - PROPOSAL JW220021 - CONTRACT PROPOSAL TITLE - EVALUATING THE SAFETY AND EASE OF USE OF COUNTERFLOW HEMOSTATIC GAUZE FOR EXTREME COLD ENVIRONMENTS

Likely rebid window (estimate)

  • Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
  • RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)

In the final months before the current end date.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Defense (NAICS 541714)